EXCLUSIVE: See the presentation Cedar used to convince investors like Andreessen Horowitz to invest $102 million

Hollis Johnson/Business Insider


Welcome to Dispensed Daily, your daily dose of healthcare news from Business Insider.

New to the newsletter? You can sign up here to get this email in your inbox every day.

Let’s dive into today’s top stories from the healthcare team.

CedarCedar president Arel Lidow and CEO Dr. Florian Otto

The presentation digital health startup Cedar used in convincing Andreessen Horowitz to lead its $US102 million round

In healthcare startup-land, the week got off to a start with a fresh $US102 million round for Cedar, a four-year-old New York startup that’s trying to make medical billing less of a pain for patients.

Zach Tracer and I got an exclusive look at the pitch deck Cedar used in the round, which was led by Andreessen Horowitz and included venture debt from JPMorgan.

The presentation shows how Cedar plans to expand beyond its initial offering, which helped make it easier to pay for a doctor visit.

You can see the full presentation here>>

We got an exclusive look at the presentation that Cedar used to convince investors like Andreessen Horowitz and JPMorgan to bet $US102 million on the digital health startup’s vision of a better way of paying for healthcare

Remdesivir2 by Getty ImagesULRICH PERREY/POOL/AFP via Getty ImagesVials of the drug Remdesivir pictured during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020, amidst the new coronavirus COVID-19 pandemic.

The $US96 billion biotech Gilead will start testing a new version of the first effective coronavirus treatment, and it could make remdesivir available to vastly more patients

Read the full story from Andrew Dunn here>>

A strip running a coronavirus antibody test on a blood samples.Robin Utretcht/SOPA Images/LightRocket via Getty ImagesA strip running a coronavirus antibody test on a blood samples.

Your blood type may impact how hard you get hit by the coronavirus, new research shows

  • New research suggests there could be a link between a patient’s blood type and their risk of a severe coronavirus infection.
  • An analysis of thousands of coronavirus patients in Spain and Italy showed that people with blood type A are 50% more likely to develop severe symptoms and require ventilation.
  • The researchers also noted that people with blood type O are less likely to contract severe infections.

Read the full story from Insider’s Aylin Woodward here>>

More stories we’re reading:

Thanks for reading Dispensed Daily, a daily version of my weekly Dispensed email. What do you think? What would you like to see every morning? I’m at [email protected]. You can subscribe to the daily email here.

– Lydia

Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.